Eplet mismatch imputation studies should include immunologic risk assessment
Am J Transplant
.
2021 Oct;21(10):3500-3501.
doi: 10.1111/ajt.16562.
Epub 2021 Mar 30.
Authors
Scott M Krummey
1
,
Robert A Bray
2
,
Howard M Gebel
2
,
Harold C Sullivan
2
Affiliations
1
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
2
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
PMID:
33728758
DOI:
10.1111/ajt.16562
No abstract available
Keywords:
clinical decision-making; clinical research / practice; crossmatch; histocompatibility.
Publication types
Letter
Comment
MeSH terms
Graft Rejection* / etiology
Histocompatibility Testing
Risk Assessment